P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
ABBV | 23.4 | 10.8 | 0.2 | +137.07% |
ABBV Peer | 48.8 | 35.6 | N/A | -9.81% |
Pharmaceuticals: Major Industry | 23.3 | 15.9 | 0.3 | +54.13% |
Health Technology Sector | 32.2 | 21.2 | 0.6 | +119.66% |
S&P 500 Market | 30.9 | 30.3 | 1.0 | +99.31% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | $3.43 | $3.67 | $3.78 | $3.21 |
Previous Mean | N/A | $3.67 | $3.78 | N/A |
Standard Deviation | 0.05 | 0.08 | 0.13 | 0.18 |
Low Estimate | $3.34 | $3.55 | $3.57 | $3.08 |
High Estimate | $3.53 | $3.83 | $4.04 | $3.33 |